264 related articles for article (PubMed ID: 11135250)
21. Cerebellar susceptibility to experimental autoimmune encephalomyelitis in SJL/J mice: potential interaction of immunology with vascular anatomy.
Tonra JR
Cerebellum; 2002; 1(1):57-68. PubMed ID: 12879974
[TBL] [Abstract][Full Text] [Related]
22. Loss of astrocyte polarity marks blood-brain barrier impairment during experimental autoimmune encephalomyelitis.
Wolburg-Buchholz K; Mack AF; Steiner E; Pfeiffer F; Engelhardt B; Wolburg H
Acta Neuropathol; 2009 Aug; 118(2):219-33. PubMed ID: 19533155
[TBL] [Abstract][Full Text] [Related]
23. Delayed, relapsing experimental allergic encephalomyelitis in mice.
Lublin FD; Maurer PH; Berry RG; Tippett D
J Immunol; 1981 Mar; 126(3):819-22. PubMed ID: 7462632
[TBL] [Abstract][Full Text] [Related]
24. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates experimental autoimmune encephalomyelitis via modulation of endothelial-monocyte interaction.
Prasad R; Giri S; Nath N; Singh I; Singh AK
J Neurosci Res; 2006 Aug; 84(3):614-25. PubMed ID: 16770773
[TBL] [Abstract][Full Text] [Related]
25. Cationic liposomes target sites of acute neuroinflammation in experimental autoimmune encephalomyelitis.
Cavaletti G; Cassetti A; Canta A; Galbiati S; Gilardini A; Oggioni N; Rodriguez-Menendez V; Fasano A; Liuzzi GM; Fattler U; Ries S; Nieland J; Riccio P; Haas H
Mol Pharm; 2009; 6(5):1363-70. PubMed ID: 19281192
[TBL] [Abstract][Full Text] [Related]
26. An electrophysiological model of spinal transmission deficits in mouse experimental autoimmune encephalomyelitis.
Hanak SE; Reilly EM; Wotanis J; Zhu B; Pulicicchio C; McMonagle-Strucko K; Wettstein JG; Black MD
J Pharmacol Exp Ther; 2004 Jan; 308(1):214-20. PubMed ID: 14566007
[TBL] [Abstract][Full Text] [Related]
27. PSGL-1 is not required for development of experimental autoimmune encephalomyelitis.
Osmers I; Bullard DC; Barnum SR
J Neuroimmunol; 2005 Sep; 166(1-2):193-6. PubMed ID: 16005524
[TBL] [Abstract][Full Text] [Related]
28. Expression of glutamate transporters GLT-1 and GLAST in different regions of rat brain during the course of experimental autoimmune encephalomyelitis.
Mitosek-Szewczyk K; Sulkowski G; Stelmasiak Z; Struzyńska L
Neuroscience; 2008 Jul; 155(1):45-52. PubMed ID: 18572325
[TBL] [Abstract][Full Text] [Related]
29. Targeted expression of IGF-1 in the central nervous system fails to protect mice from experimental autoimmune encephalomyelitis.
Genoud S; Maricic I; Kumar V; Gage FH
J Neuroimmunol; 2005 Nov; 168(1-2):40-5. PubMed ID: 16120466
[TBL] [Abstract][Full Text] [Related]
30. Lack of TIMP-1 increases severity of experimental autoimmune encephalomyelitis: Effects of darbepoetin alfa on TIMP-1 null and wild-type mice.
Thorne M; Moore CS; Robertson GS
J Neuroimmunol; 2009 Jun; 211(1-2):92-100. PubMed ID: 19428125
[TBL] [Abstract][Full Text] [Related]
31. Susceptibility-weighted imaging in the experimental autoimmune encephalomyelitis model of multiple sclerosis indicates elevated deoxyhemoglobin, iron deposition and demyelination.
Nathoo N; Agrawal S; Wu Y; Haylock-Jacobs S; Yong VW; Foniok T; Barnes S; Obenaus A; Dunn JF
Mult Scler; 2013 May; 19(6):721-31. PubMed ID: 23027879
[TBL] [Abstract][Full Text] [Related]
32. Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis.
Brown DA; Sawchenko PE
J Comp Neurol; 2007 May; 502(2):236-60. PubMed ID: 17348011
[TBL] [Abstract][Full Text] [Related]
33. Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis.
Dittel BN
Arch Immunol Ther Exp (Warsz); 2000; 48(5):381-8. PubMed ID: 11140465
[TBL] [Abstract][Full Text] [Related]
34. Blood-brain barrier changes and cell invasion differ between therapeutic immune clearance of neurotrophic virus and CNS autoimmunity.
Fabis MJ; Phares TW; Kean RB; Koprowski H; Hooper DC
Proc Natl Acad Sci U S A; 2008 Oct; 105(40):15511-6. PubMed ID: 18829442
[TBL] [Abstract][Full Text] [Related]
35. [Effect of experimental allergic encephalomyelitis on the intensity of phospholipid metabolism in the brain and spinal cord].
Zuber VL; Taranova NP
Vopr Med Khim; 1978; 24(3):322-6. PubMed ID: 664458
[TBL] [Abstract][Full Text] [Related]
36. Cerebrospinal fluid levels of neurofilament light in chronic experimental autoimmune encephalomyelitis.
Norgren N; Edelstam A; Stigbrand T
Brain Res Bull; 2005 Oct; 67(4):264-8. PubMed ID: 16182933
[TBL] [Abstract][Full Text] [Related]
37. Dynamic changes in meningeal inflammation correspond to clinical exacerbations in a murine model of relapsing-remitting multiple sclerosis.
Walker-Caulfield ME; Hatfield JK; Brown MA
J Neuroimmunol; 2015 Jan; 278():112-22. PubMed ID: 25595260
[TBL] [Abstract][Full Text] [Related]
38. Neutrophils mediate blood-spinal cord barrier disruption in demyelinating neuroinflammatory diseases.
Aubé B; Lévesque SA; Paré A; Chamma É; Kébir H; Gorina R; Lécuyer MA; Alvarez JI; De Koninck Y; Engelhardt B; Prat A; Côté D; Lacroix S
J Immunol; 2014 Sep; 193(5):2438-54. PubMed ID: 25049355
[TBL] [Abstract][Full Text] [Related]
39. Immunologic studies of chronic relapsing EAE in guinea pigs: similarities to multiple sclerosis.
Mehta PD; Lassmann H; Wisniewski HM
J Immunol; 1981 Jul; 127(1):334-8. PubMed ID: 7240747
[TBL] [Abstract][Full Text] [Related]
40. Expression of TNF alpha in central neurons of Lewis rat spinal cord after EAE induction.
Villarroya H; Marie Y; Ouallet JC; Le Saux F; Tchélingérian JL; Baumann N
J Neurosci Res; 1997 Sep; 49(5):592-9. PubMed ID: 9302080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
